RE:RE:RE:RE:RE:RE:News
Wildk:
While i think the IND is important to advance the trial and will be able to get more patients treated faster, I still believe the results are what matter. Now hopefully we will get them quicker. The IND probably won't turn too many heads other than us shareholders want to trial to advance. Break thru status or Accelerated Approval will get ppl talking a bit more and I think we all need some new investors to really see the price move...
G1